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Abstract
Proliferating cell nuclear antigen (PCNA) has been shown to interact with a variety of DNA
polymerases (pol) such as pol delta, pol epsilon, pol iota, pol kappa, pol eta, and pol beta. Here we show
that PCNA directly interacts with the newly discovered pol lambda cloned from human cells. This
interaction stabilizes the binding of pol lambda to the primer template, thus increasing its affinity for the
hydroxyl primer and its processivity in DNA synthesis. However, no effect of PCNA was detected on
the rate of nucleotide incorporation or discrimination efficiency by pol lambda. PCNA was found to
stimulate efficient synthesis by pol lambda across an abasic (AP) site. When compared with pol delta,
human pol lambda showed the ability to incorporate a nucleotide in front of the lesion. Addition of
PCNA led to efficient elongation past the AP site by pol lambda but not by pol delta. However, when
tested on a template containing a bulky DNA lesion, such as the major cisplatin Pt-d(GpG) adduct,
PCNA could not allow translesion synthesis by pol lambda. Our results suggest that the complex
between PCNA and pol lambda may play an important role in the bypass of abasic sites in human cells.
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Proliferating cell nuclear antigen (PCNA) has been
shown to interact with a variety of DNA polymerases
(pol) such as pol , pol , pol , pol , pol , and pol . Here
we show that PCNA directly interacts with the newly
discovered pol  cloned from human cells. This interac-
tion stabilizes the binding of pol  to the primer tem-
plate, thus increasing its affinity for the hydroxyl
primer and its processivity in DNA synthesis. However,
no effect of PCNA was detected on the rate of nucleotide
incorporation or discrimination efficiency by pol .
PCNA was found to stimulate efficient synthesis by pol 
across an abasic (AP) site. When compared with pol ,
human pol  showed the ability to incorporate a nucle-
otide in front of the lesion. Addition of PCNA led to
efficient elongation past the AP site by pol  but not by
pol . However, when tested on a template containing a
bulky DNA lesion, such as the major cisplatin Pt-d(GpG)
adduct, PCNA could not allow translesion synthesis by
pol . Our results suggest that the complex between
PCNA and pol  may play an important role in the by-
pass of abasic sites in human cells.
In the last few years the number of known eukaryotic DNA
polymerases (pols),1 including terminal transferase and telom-
erase, has increased to at least 19 (1). A particular pol might
have more than one functional task in a cell, and a particular
DNA transaction may require more than one pol, suggesting
that nature has provided various safety mechanisms. This mul-
tifunctional feature is especially valid for the variety of novel
pols identified in the last 3 years. These are the lesion-repli-
cating enzymes pol , pol , pol , pol , and Rev1, and a group
of pols called pol , pol , pol , pol , and pol 	 that fulfill a
variety of other tasks. The gene encoding the novel pol  was
cloned and mapped to mouse chromosome 19 and to human
chromosome 10 (2, 3). pol  contains all the critical residues
involved in DNA binding, nucleotide binding, nucleotide selec-
tion, and catalysis of DNA polymerization and has been as-
signed to family X based on sequence homology with pol 
, pol
, and terminal deoxynucleotidyltransferase. pol  has been
suggested to play a role in meiotic recombination and DNA
repair, and the recent demonstration of an intrinsic 5-deoxy-
ribose-5-phosphate lyase activity in pol  supports a function of
this enzyme in base excision repair (4, 5). Cloned and purified
human (h) pol  inserts nucleotides in a DNA template-depend-
ent manner and is processive in small gaps containing a 5-
phosphate group. These properties, together with its nucleotide
insertion fidelity parameters and lack of proofreading activity,
indicate that hpol  is a novel pol 
-like enzyme (5). Recently,
pol  was purified from calf thymus tissue, and the biochemical
properties of the native calf thymus pol  were shown to be
similar to the recombinant hpol  protein (6). In particular, it
has been shown that the native calf thymus enzyme was able to
synthesize DNA on a template containing abasic (AP) sites
with the same efficiency as on undamaged DNA, thus suggest-
ing a potential role of pol  in translesion synthesis. The in vivo
function of pol  has also been addressed by using transgenic
null mice but with conflicting results (7, 8).
PCNA is a highly conserved eukaryotic protein essential for
DNA replication and repair (9, 10). In DNA replication PCNA
acts as the processivity factor for pol  and pol  and plays an
important role in coordinating leading and lagging strand syn-
thesis (11). Kinetic analysis showed that the mechanism of
PCNA interaction with pol  and pol  is different. PCNA
increased the stability of the pol -DNA primer complex (thus
reducing the dissociation rate of the enzyme from the DNA
template) without affecting the nucleotide incorporation step
(12), whereas for pol  PCNA increased the association rate of
the enzyme to the DNA primer and also the nucleotide incor-
poration rate without affecting the dissociation step (13, 14).
The amount of PCNA in the cell is more than 10-fold that of pol
, suggesting that this protein might have roles in addition to
that of a polymerase accessory factor. Indeed, several PCNA-
binding proteins have been discovered with various functions
such as Okazaki fragment processing, DNA repair, DNA meth-
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ylation, chromatin remodeling, and cell cycle control. Most of
these proteins share a consensus sequence for PCNA binding
designated as the PCNA interacting proteins box (15–17).
Among its recently discovered partners are some of the novel
eukaryotic pols, namely hpol , hpol , and hpol  (18–21).
PCNA has been shown to stimulate their DNA synthetic activ-
ity on both undamaged and damaged DNA, but the processivity
of these enzymes was not significantly increased. Steady-state
kinetic studies indicated a novel mechanism for this stimula-
tion that was caused by an increase in the efficiency of nucle-
otide insertion and resulted from a reduction in the apparent
Km for the incoming nucleotide. As a result, the efficiency of
correct versus incorrect nucleotide incorporation and the incor-
poration in front of a variety of DNA lesions was increased.
Recently a direct interaction of PCNA with pol 
 was shown
that might have potential implications in the mechanism of
short-patch base excision repair (22). In light of the similarity
between pol 
 and pol , in the present work we wanted to
investigate the effect of PCNA on the activity of hpol . We
show that PCNA directly binds to hpol  and stimulates its
activity. However, this stimulation appears to take place by a
mechanism that is different from the cases of hpol , hpol ,
and hpol , closely resembling the interaction of PCNA with pol
. Indeed PCNA stabilizes the binding of pol  to the primer/
template, thus increasing its processivity without affecting the
affinity for the nucleotide substrate or the misincorporation
efficiency. Furthermore, PCNA increases the efficiency of DNA




[3H]dTTP (40 Ci/mmol) and [-32P]dCTP (3000 Ci/mmol) were from
Amersham Biosciences; unlabeled dNTPs, poly(dA), and oligo(dT)12–18
were from Roche Molecular Biochemicals. The tetrahydrofuran
(dSpacer) was from Glen Research. Activated calf thymus DNA was
prepared as described (23). Whatman was the supplier of the GF/C
filters. All other reagents were of analytical grade and were purchased
from Merck or Fluka.
Nucleic Acid Substrates
The d60-mer containing the Pt-d(GpG) adduct was constructed as
described (24). The undamaged d72-mer, the d73-mer containing the
synthetic (tetrahydrofuran) AP site, and the corresponding primers
were chemically synthesized and purified on denaturing polyacryla-




GGTAGTATGGTGGATA-3; and d60-mer, 5-GGTGGTGGTGGGCGC-
CGGCGGTGTGAATTCGGCACTGGCCGTCGTATGCTCTTGGTTGT-
A-3. The sequences that are complementary to the corresponding
primers are underlined. Bold letters indicate the position of the respec-
tive lesions (X, AP site; GG, Pt-d(GpG) adduct).
Enzymes and Proteins
Recombinant hpol  was expressed and purified as described (5).
Mammalian pol  and pol  were purified as described (23) and had
specific activities of 25,000 units/ml (0.2 mg/ml) for pol  and 50,000
units/ml (0.1 mg/ml) for pol . 1 unit of pol activity corresponds to the
incorporation of 1 pmol of total dTMP into acid-precipitable material in
60 min at 37 °C in a standard assay containing 0.5 g (nucleotides) of
poly(dA)/oligo(dT)10:1 and 20 M dTTP. Recombinant human PCNA was
isolated as described (14, 25). Phosphorylated recombinant human
PCNA was prepared as described (26). Escherichia coli pol I (Klenow
fragment) was from Roche Molecular Biochemicals.
Enzymatic Assays
DNA Polymerase Assay—pol  activity on poly(dA)/oligo(dT)10:1
was assayed in a final volume of 25 l containing 50 mM Tris-HCl (pH
7.6), 0.25 mg/ml bovine serum albumin, 1 mM DTT, 0.5 mM MnCl2,
and 5 M [3H]dTTP (5 Ci/mmol) unless otherwise indicated in the
figure legends. All reactions were incubated for 15 min at 37 °C
unless otherwise stated, and the DNA was precipitated with 10%
trichloroacetic acid. Insoluble radioactive material was determined
by scintillation counting as described (27). For sequencing gel anal-
ysis the reaction mixture included 50 mM Tris-HCl (pH 7.6), 0.25
mg/ml bovine serum albumin, 1 mM DTT, 0.5 mM MnCl2, 5 M each of
unlabeled dNTPs, and 32P-5 end-labeled DNA template as indicated
in the figure legends. For the processivity assay, reactions were
performed in the presence of 40-fold molar excess over the labeled
template of poly(dA)/oligo(dT) as a trap.
Misincorporation Assay—pol activity on AP or Pt-d(GpG)-contain-
ing oligonucleotides was assayed in a final volume of 10 l containing
50 mM Tris-HCl (pH 7.6), 0.25 mg/ml bovine serum albumin, 1 mM
DTT, 0.5 mM MnCl2, and the 5-labeled primer/template as indicated
in the figure legends. pol activity was assayed in the absence or in the
presence of 1 M of either dTTP, dATP, dGTP, or dCTP. All reactions
were incubated for 15 min at 37 °C unless otherwise stated, stopped
by addition of sequencing gel loading buffer, and heated for 3 min at
95 °C. Reaction products were resolved on a 20% polyacrylamide, 7 M
urea gel.
Electrophoretic Mobility Shift Assay (EMSA)
The EMSA was performed in a final volume of 10 l containing 50
mM Tris-HCl (pH 7.6), 0.25 mg/ml bovine serum albumin, 1 mM DTT, 1
mM MnCl2 in the presence of 2 pmol of pol  and 5 pmol of 5-labeled
d17:d72-mer oligonucleotide. Samples were incubated for 5 min at 25 °C
to form enzyme-DNA complexes and were then diluted 10-fold in the
same buffer containing 50 pmol of poly(dA)/oligo(dT) and 1% formalde-
hyde at the specified time points. After an additional 2 min at 25 °C,
samples were mixed with non-denaturing gel loading buffer and re-
solved by native gel electrophoresis on a 8% polyacrylamide gel.
Pull-down Assay
Pull-down experiments were performed by incubating 20 pmol (as
trimer) of 32P-labeled human/PCNA with nickel-nitrilotriacetic acid-
agarose beads in the absence or in the presence of 10 pmol of histidine-
tagged hpol  in buffer A (50 mM Tris-HCl (pH 7.6), 1 mM DTT, 0.1 M
NaCl, 0.005% Nonidet P-40). Inclusion of 1 mM DTT was found to
increase the specificity of binding and reduce the background. After
extensive washing in buffer A containing 20 mM imidazole, proteins
bound to the beads were eluted with buffer A containing 1 M imidazole
and analyzed by SDS-PAGE.
Steady-state Kinetic Data Analysis
For kinetic analysis, time-dependent nucleotide incorporation was
measured in the presence of increasing concentrations of DNA or nu-
cleotide substrate. The slopes of the curves obtained by linear interpo-
lation of the data points were taken as the initial velocities of the
reaction at any given substrate concentration. The Km and Vmax values
were calculated by plotting the initial velocities in dependence of the
substrate concentrations and fitting the data according to the Michae-







where kcatE0  Vmax.
The steady-state rates (kss) of synthesis values for time-dependent
nucleotide incorporation by pol  on the undamaged template were
determined according to the exponential equation,
(products)  A1  ekbt ksst (Eq. 2)
where A is the burst amplitude and t is time. The products were
calculated from the values of integrated gel band intensities I*T/IT1,
where T is the target site, the template position of interest and I*T is the
sum of the integrated intensities at positions T, T1 . . . Tn.
RESULTS
Human PCNA Stimulates the Processivity of Human DNA
Polymerase —Fig. 1 shows a time course of nucleotide incor-
poration by pol  on a sp17:72-mer oligonucleotide primer tem-
plate in the absence (panels A and C) or in the presence (panels
B and D) of PCNA. Under distributive conditions the compar-
ison of the reaction products at the different time points re-
vealed an apparent slower DNA synthesis by pol  in the
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presence of PCNA, with the accumulation of 30 nucleotide
products after 8 min and few full-length products appearing
after only 15 min (compare Fig. 1, A with B). The same exper-
iment was then repeated under processive conditions (Fig. 1, C
and D), i.e. in the presence of an excess of cold poly(dA)/oli-
go(dT) as a trapping reagent. In this case, a 5–6-fold proces-
sivity increase was evident in the presence of PCNA. In fact,
without PCNA pol  showed a processivity of about 5 nucleo-
tides (Fig. 1C), which was increased to 25 nucleotides in the
presence of PCNA (Fig. 1D). The apparent rate of DNA synthe-
sis was 0.012 ( 0.002) s1 without PCNA and 0.06 ( 0.01) s1
in its presence. These results clearly indicated that pol  is a
highly distributive enzyme whose processivity is enhanced by
PCNA and suggested that the apparently slower DNA synthe-
sis observed in Fig. 1B could be caused by a reduced dissocia-
tion rate of the pol from the DNA template. The experiment
shown in Fig. 1A shows that after 5 min of incubation DNA
products longer than 72 nucleotides appeared. These could be
caused by template slippage of pol  at the GC-rich sequences
of the template strand. Apparently, pol  was able to add 12–13
extra nucleotides at the last time point analyzed. Taking into
account the calculated rate of DNA synthesis and the length of
the template to be replicated, this was compatible with one
extra nucleotide added every five to six incorporation events.
This latter value corresponds to the processivity observed with
pol  for a single binding event (Fig. 1C), further supporting the
hypothesis of a template-slippage mechanism. Significantly,
fewer extra nucleotides were added in the presence of PCNA
under distributive conditions (Fig. 1B).
PCNA Increases the Affinity of DNA Polymerase  for the
3-Hydroxyl Primer—To further investigate the mechanism of
interaction of PCNA with human pol , the variation of the
initial velocities of the reaction catalyzed by pol  was meas-
ured in the absence or in the presence of increasing amounts of
PCNA. From each series of measurements, the affinity values
(Km) and the catalytic rates (kcat) were calculated. As shown in
Fig. 2A, the affinity of pol  for the 3-OH primer was increased
by PCNA in a dose-dependent manner as indicated by the
decrease of the apparent Km values. Correspondingly, the effi-
ciency of primer utilization (kcat/Km value) was increased (Fig.
2B). When the variation of the Km and kcat/Km values was
plotted with regard to the PCNA concentration, as shown in
Fig. 2, C and D, respectively, both curves fitted to an hyperbolic
equation that allowed the calculation of apparent dissociation
constants for PCNA of 30.1 ( 0.5) nM and 26.5 ( 0.8) nM,
respectively. These values were very close to the Km for the
3-OH primer calculated in the absence of PCNA (29.3 ( 0.8)
nM). The fact that the amount of PCNA required for half-
maximal stimulation was almost identical to the concentration
of 3-OH primer ends required to half-saturate the pol  active
site suggests that PCNA binds pol  with the same stoichiom-
etry as the 3-OH primer. Thus, it appears that pol , PCNA,
and the 3-OH primer form an equimolar complex.
PCNA Does Not Influence the Affinity or the Incorporation⁄
Misincorporation Efficiency of DNA Polymerase  for the Nu-
FIG. 1. PCNA increases the processivity of pol . A, time-depend-
ent elongation of a d17:d72-mer primer/template by pol  in the absence
of PCNA under distributive conditions. B, time-dependent elongation of
a d17:d72-mer primer/template by pol  in the presence of PCNA under
distributive conditions. Reactions shown in panels A and B were carried
out as described under “Materials and Methods” in the presence of 1
pmol of pol  and 0.25 pmol of 5-labeled DNA template. C, time-de-
pendent elongation of a d17:d72-mer primer/template by pol  in the
absence of PCNA under processive conditions. D, time-dependent elon-
gation of a d17:d72-mer primer/template by pol  in the presence of
PCNA under processive conditions. Reactions shown in panels C and D
were carried out as described under “Materials and Methods” in the
presence of 1 pmol of pol , 0.25 pmol of 5-labeled DNA template, and
10 pmol of unlabeled poly(dA)/oligo(dT) as the trap. nt, nucleotide.
FIG. 2. PCNA increases the efficiency of primer utilization by
pol . A, dependence of the apparent Km for the 3-OH primer of pol 
from the PCNA concentration. Km values were determined as described
under “Materials and Methods” in the presence of 0.5 pmol of pol  and
5 pmol of poly(dA)/oligo(dT) (as 3-OH ends). B, dependence of the
catalytic efficiency kcat/Km of pol  from the PCNA concentration. Km
and kcat values were determined as described under “Materials and
Methods” in the presence of 0.5 pmol of pol  and 5 pmol of poly(dA)/
oligo(dT) (as 3-OH ends). C, dependence of the increase (Incr) in affin-
ity of pol  for the 3-OH primer from the PCNA concentration. Data
points were fitted to the equation, Incr  Incrmax/(1  (Kd/[PCNA])),
where Incr  1(Kapp/Km). D, dependence of the increase of kcat/Km of
pol  for the 3-OH primer from the PCNA concentration. Data were
fitted to the equation, ‚(kcat/Km)  ‚max/(1  (Kd/[PCNA])).
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cleotide Substrate—Previous reports have shown that PCNA
increased the affinity for the nucleotide substrate of pol , ,
and . To verify whether PCNA had the same effect on pol ,
the dependence of the reaction velocity from the dTTP con-
centration was tested in the absence or in the presence of
increasing amounts of PCNA. As shown in Fig. 3A, PCNA did
not significantly change the affinity of pol  for the substrate
dTTP, which showed a Km value of 3.6 ( 0.1) M in its
absence and 3.3 ( 0.2) M in its presence. These results
indicated that the effect of PCNA was specifically to increase
the stability of the complex between pol  and the primer
template. Next, we tested whether PCNA affected the incor-
poration efficiency of correct versus wrong nucleotides by pol
. As shown in Fig. 3B, lane 2, addition of the first encoded
nucleotide (dTTP) resulted in termination of synthesis at
position 1, as expected, whereas in the presence of all four
nucleotides full-length synthesis was achieved (lane 5). Lim-
ited misincorporation was observed at position 1 when only
dATP (lane 4) was added but not with dGTP (lane 1). Inter-
estingly, when only dCTP was added to the reaction mixture
(lane 3) a product appeared at position 3. When the same
experiment was repeated in the presence of PCNA (Fig. 3C),
there was an increase in the 1 product synthesized in the
presence of dTTP (lane 2) as well as in the full-length product
synthesized in the presence of all four dNTPs (lane 5), ac-
cording to the fact that PCNA increases the efficiency of
primer utilization. However, no significant changes could be
detected in the misincorporation ability of pol . The product
appearing in Fig. 3B, lane 3, can be explained as a combina-
tion of limited misincorporation and template slippage; after
addition of the first cytosine residues (encoded by the two
guanosine residues in the template), reannealing of the tem-
plate allowed insertion of an additional cytosine. Therefore, a
mismatch dA/dCMP is introduced followed by two correct
dG/dCMP pairs. The apparent misinsertion of dAMP (lane 4
in Fig. 3B) could be explained also if the two guanosine
residues at positions 2 and 3 of the template could be
misaligned to pair with the two cytosine residues at the
primer terminus. If this is the case with pol  in this sequence
context, it appears that the presence of PCNA is not able to
inhibit such an “abnormal” templating. All together these
results suggested that PCNA did not influence the nucleotide
discrimination efficiency of pol .
A Direct Physical Association of PCNA with pol  Stabilizes
the Binding of the Enzyme to the Primer⁄Template by Reducing
Its Dissociation Rate—The results presented above suggested
that PCNA increases the processivity of pol  and its apparent
affinity for the 3-OH primer end, possibly by increasing the
residence time of pol  at the primer/template junction. To
directly test this hypothesis, an EMSA was performed with
5-labeled 17:72-mer oligonucleotide in which preformed pol
-DNA complexes were challenged at different time points with
an excess of poly(dA)/oligo(dT) trap and 1% formaldehyde. At
any given time point the fraction of unbound enzyme should be
trapped by the cold DNA, whereas formaldehyde should allow
fixation of the fraction of pol  bound to labeled DNA. As shown
in Fig. 4A, in the presence of PCNA slower dissociation of pol 
FIG. 3. PCNA does not influence the nucleotide misincorpora-
tion/incorporation ability of pol . A, PCNA does not change the
apparent affinity of pol  for the nucleotide substrate. The dependence
of the reaction velocity of pol  from the dTTP concentration was
measured in the presence of 0.5 pmol of enzyme and 5 pmol of poly(dA)/
oligo(dT) (in terms of 3-OH primer ends) and in the absence (circles) or
in the presence of 10 nM (triangles), 20 nM (squares), and 50 nM (dia-
monds) PCNA. B, DNA synthesis catalyzed by human pol  on a
d17:d73 oligonucleotide. Reactions were performed as described under
“Materials and Methods” in the presence of 0.2 pmol of enzyme and 0.5
pmol of DNA substrate and in the absence (lane 6) or in the presence of
1 M dGTP (lane 1), 1 M dTTP (lane 2), 1 M dCTP (lane 3), 1 M dATP
(lane 4), or the mixture of all four dNTPs (1 M each) (lane 5). C, the
same experiment as described in panel B but in the presence of 50 nM
PCNA. nt, nucleotide.
FIG. 4. PCNA physically interacts with pol  and specifically
stabilizes its binding to the template/primer. A, time-dependent
dissociation of the pol -DNA complex in the absence (lanes 1–4) or in
the presence (lanes 5–8) of PCNA. The EMSA was performed as de-
scribed under “Materials and Methods” in the presence of 2 pmol of pol
 and 5 pmol of 5-labeled d17:d72-mer oligonucleotide. Bound, repre-
sents oligonucleotide complexed with pol ; Free, represents unbound
oligonucleotide. B, quantification of the results of the experiment shown
in panel A. The percentage of enzyme bound was plotted versus time,
and the data were fitted to a simple exponential to calculate the disso-
ciation rate (koff). C, PCNA directly interacts with pol  in the absence
of DNA. Pull-down experiments were performed as described under
“Materials and Methods” in the presence of 20 pmol (as trimer) of
32P-labeled PCNA and in the absence or in the presence of 10 pmol of
His-tagged pol .
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was observed as indicated by the higher amount of enzyme-
DNA complex present at any time point (compare lanes 1–4
with lanes 5–8). Quantification of the bound fraction allowed
the fitting of the curves to a simple exponential with dissocia-
tion rates of 0.0086 (2  103) s1 in the absence of PCNA
and 0.0032 (8  104) s1 in its presence (Fig. 4B). In addi-
tion, to verify whether pol  and PCNA directly interacted a
pull-down assay was performed with radiolabeled PCNA and
His-tagged pol . Nickel-nitrilotriacetic acid-agarose beads
were incubated with C-terminal-labeled PCNA alone or in com-
bination with His-tagged pol . After extensive washing, beads
were eluted with 1 M imidazole, and the eluted proteins were
loaded onto a SDS-polyacrylamide gel. As shown in Fig. 4C,
nickel-nitrilotriacetic acid-agarose beads incubated with PCNA
alone resulted only in a background level of bound PCNA.
However, inclusion of pol  resulted in significant binding of
PCNA. These results indicated that PCNA interacted function-
ally and physically with pol .
PCNA Promotes Translesion DNA Synthesis by DNA Polym-
erase  at an Abasic Site but Not at a Cis-Pt Adduct—The
results presented so far indicated that PCNA interacts with pol
 and increases its residence time on the DNA template. Be-
sides providing pol  with higher processivity, this interaction
could influence the ability of the enzyme to bypass sites along
the template sequence where it normally would dissociate (e.g.
at DNA lesions). To address this point, the effect of PCNA was
evaluated on the ability of pol  to replicate across two different
lesions: first, an AP site and second, a cis-Pt d(GpG) adduct. AP
sites are very common non-instructional lesions that can arise
spontaneously in the DNA as a consequence of normal cellular
metabolism. On the other hand, cisplatin, a clinically used
anticancer drug, causes bulky DNA adducts, the prominent one
being formed between two adjacent guanines on the same DNA
strand (Pt-d(GpG)). Both lesions are able to block DNA synthe-
sis in vitro by the replicative pols , , and . As shown in Fig.
5A, a d17:d73-mer primer template containing a single syn-
thetic AP site (tetrahydrofuran moiety) at a defined position on
the template strand was used as the substrate for DNA syn-
thesis by pol  in the absence or in the presence of PCNA.
Without added PCNA pol  mainly incorporated a nucleotide at
the position corresponding to the AP site and stopped, although
a limited elongation from the nucleotide incorporated in front
of the lesion was also observed (Fig. 5A, lane 3). When increas-
ing amounts of PCNA were added, however, pol  was able to
efficiently bypass the AP lesion synthesizing full-length 73-
nucleotide products in a PCNA dose-dependent manner (Fig.
5A, lanes 4 and 5). E. coli pol I was used as a positive control for
lesion bypass (Fig. 5A, lane 2). When the major cellular PCNA-
dependent replicative enzyme pol  was tested under similar
conditions a different result was obtained. As shown in Fig. 5B,
in the presence of PCNA pol  was stopped at the position
immediately before the AP site (Fig. 5B, lane 1). When increas-
ing amounts of PCNA were added, significant incorporation in
front of the lesion was achieved, but no subsequent elongation
was detected (Fig. 5B, lanes 2–5) even in the presence of satu-
rating amounts of PCNA. Thus, pol  showed the ability to
catalyze both incorporation in front of the abasic lesion and
subsequent elongation of the nucleotide opposite the AP site in
a PCNA-stimulated manner. When the ability of pol  to bypass
an AP site was tested in the presence of increasing dNTP
concentrations (Fig. 5C), PCNA was again found to promote
translesion synthesis as revealed by the increase in the full-
length products at low dNTP concentrations (compare lanes
1–3 to lanes 6–8), but the overall nucleotide incorporation
efficiency of pol  was not affected (kcat/Km values were 2.7
(0.3)  103 M1 s1 in the absence of PCNA and 3.3 (0.3) 
103 M1 s1 in its presence). It is known that the replicative
pols , , and  cannot bypass the Pt-(GpG) adduct, whereas pol

 is able to make translesion synthesis opposite to it, a capacity
that it shares with E. coli pol I (24). Because pol  shares
significant homology to pol 
, we were interested in verifying
its ability to bypass this cisplatin lesion. As shown in Fig. 5D,
pol  could not synthesize across the lesion placed on a d17:
d60-mer primer template, showing a strong stop at the position
immediately before the guanosine implicated in the adduct
exactly the same as pol  (compare lane 3 to lanes 5–7) and pol
 (data not shown). When increasing amounts of PCNA were
FIG. 5. PCNA increases translesion synthesis by pol  past an
abasic site but not past a cis-Pt adduct. A, DNA synthesis catalyzed
by 0.1 unit of E. coli pol I (lane 2) or 0.5 pmol of human pol  (lanes 3–5)
on a d17:d73 oligonucleotide (5 pmol) with a single synthetic AP site at
position 32 (indicated by an asterisk). Reactions were performed as
described under “Materials and Methods” in the absence (lane 3) or in
the presence of 25 nM (lane 4) and 50 nM (lane 5) PCNA. Lane 1 (C),
control reaction without enzyme. B, DNA synthesis catalyzed by 0.1
unit of E. coli pol I (lane 2) or 0.1 unit of human pol  (lanes 3–5) on a
d17:d73 oligonucleotide (5 pmol) with a single synthetic AP site at
position 32 (indicated by an asterisk). Reactions were performed as
described under “Materials and Methods” in the absence (lane 1) or in
the presence of 25 nM (lane 2), 50 nM (lane 3), 75 nM (lane 4), and 150 nM
(lane 5) PCNA. M, 5-labeled single-strand 17-mer and single-stand
73-mer oligonucleotides were loaded as markers. C, DNA synthesis
catalyzed by 0.5 pmol of human pol  on a d17:d73 oligonucleotide (5
pmol) with a single synthetic AP site at position 32 (indicated by an
asterisk). Reactions were performed as described under “Materials and
Methods” in the absence (lanes 1–5) or in the presence (lanes 6–10) of 50
nM PCNA and in the presence of increasing dNTP concentrations as
indicated. Lane C, control reaction in the absence of pol . D, DNA
synthesis catalyzed by 0.1 unit of E. coli pol I (lane 2), 0.1 unit of human
pol  (lane 3), or 0.5 pmol of human pol  (lanes 4–7) on a d17:d60
oligonucleotide (5 pmol) with a single cis-Pt adduct at position 22
(indicated by an asterisk). Reactions were performed as described under
“Materials and Methods” in the absence (lane 4) or in the presence of 25
nM (lane 5), 50 nM (lane 6), and 75 nM (lane 7) PCNA. Lane 1 (C), control
reaction without enzyme. nt, nucleotide.
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added there was an increase in the products synthesized up to
the stop site, but no translesion synthesis was observed. Thus,
despite its similarity to pol 
, human pol  showed a different
profile of DNA lesion bypass when dealing with a bulky DNA
lesion such as the major cisplatin adduct. All of the experi-
ments were carried out in the presence of MnCl2, because this
was the optimal ion cofactor for recombinant hpol  (5). It has
been reported that for some pols (pol , pol 
, T4 pol, herpes
simplex virus pol), Mn2 ions can increase the lesion bypass
efficiency (28). However, the concentrations required to see
such effects were much higher than the one used in our assays
(0.5 mM); thus it seems unlikely that MnCl2 significantly influ-
enced the ability of pol  to bypass an AP site under these
conditions (29). In addition, when similar experiments were
performed with native calf thymus pol  in the presence of 10
mM MgCl2, efficient AP site bypass was detected, whereas no
differences were detected by replacing Mn2 with 10 mM MgCl2
for pol I, pol , and pol  under these conditions (data not
shown).
DISCUSSION
Recently pol  was purified from calf thymus tissue, and this
native calf thymus pol  was able to synthesize DNA on a
template containing abasic sites with the same efficiency as on
undamaged DNA, thus suggesting a potential role of pol  in
translesion synthesis (6). Interestingly, pol  mRNA expression
is apparently cell cycle-dependent, being higher in quiescent
and S to M phase cycling cells (3). Thus, pol  could be special-
ized in DNA repair taking place during specific stages of the
cell cycle required in nonproliferative cell types or during dif-
ferentiation processes. Such a specialized DNA repair function
of pol  might be related to the ability of the enzyme to estab-
lish distinct interactions that could regulate its cellular func-
tion(s). To investigate the specific pathway(s) recruiting this
enzyme as a first step in understanding its contribution to the
maintenance of genetic stability, we have investigated its in-
teraction with PCNA. The rationale of such an approach was
based on the recent observations that PCNA, besides acting as
a processivity factor for the replicative pols  and , was able to
interact with the repair enzyme pol 
 and with a variety of
novel translesion pols such as pol , pol , and pol , suggesting
a potential role of this protein in targeting the translesion pols
to the replication machinery. These pols have been shown to
contain a sequence closely resembling the consensus sequence
for PCNA interaction, SRGVLSFF for pol  and SMSVERTF
for pol  (the conserved PCNA-interacting protein box amino
acids are in bold) (18).2 Interestingly, inspection of the hpol 
sequence revealed the presence of a very similar box, SVPV-
LELF (amino acids 331–338). We found that PCNA directly
interacts with pol , and this interaction stabilizes the binding
of the enzyme to the template/primer as reflected by the reduc-
tion of the dissociation rate of pol  and the 5-fold increase in its
processivity (Fig. 1). However, PCNA did not influence the
affinity or the incorporation efficiency of the nucleotides by pol
 (Fig. 3); instead it increased the affinity of pol  for the
3-hydroxyl primer (Fig. 2). This was different from what has
been observed with pol , pol , and pol  where the stimulation
was caused by an increased affinity for the nucleotides (18, 19,
21). Rather, it closely resembled the mechanism of interaction
between PCNA and pol , whose processivity is stimulated as a
consequence of the reduced enzyme/DNA dissociation rate (12).
The lack of effects of PCNA on nucleotide incorporation by pol
 was also reflected by the fact that PCNA did not alter the
ability of pol  to discriminate between correct and wrong
nucleotides; pol  showed a very limited misincorporation abil-
ity either in the absence or in the presence of PCNA (Fig. 3).
When tested on a synthetic oligonucleotide containing an AP
site, PCNA was able to stimulate the incorporation of a nucle-
otide opposite the lesion by both pol  and pol . However, pol
 could also further elongate the nascent DNA strand, whereas
pol  was stalled at the lesion (compare Fig. 5, A and B). On the
other hand, PCNA failed to promote the bypass of a helix-
distorting DNA lesion such as the Pt-(GpG) adduct by pol ,
which was blocked at the position immediately preceding the
lesion. In summary our results indicate that although PCNA
stimulated translesion synthesis of pol  past an abasic site as
it did for pol , pol , and pol , it may do it by a different
mechanism of interaction with this specific polymerase. This
might reflect a different functional role of such an interaction.
Besides targeting pol  to the replication machinery, PCNA
seems likely to be able to act in cooperation with pol  to
enhance its processivity. We would like to propose a model in
which PCNA, during DNA replication, promotes incorporation
of a nucleotide opposite an abasic site by pol . The resulting
stalled replication fork might be rescued by a “switching” be-
tween pol  and pol  because of the ability of this latter pol to
elongate the nascent DNA strand. This pol switching might be
promoted by PCNA through competition between pol  (which
after stalling likely dissociates from the primer) and pol 
(which can be recruited at the lesion through its interaction
with PCNA). A mechanism for AP site bypass in eukaryotic
cells involving two different pols, one able to incorporate a
nucleotide in front of the lesion and a second one capable of
extending the newly generated primer, has already been pro-
posed (30). In that model, pol  was identified as the enzyme
responsible for the extension step. Our data support the idea
that pol , at least under certain conditions, could take up such
a role as well; moreover, the physical and functional interaction
of PCNA with pol  and, as shown here, pol  provides a logical
mechanism for the regulation of the concerted action of these
two pols.
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